Skip to main content
Powered by
buzzwords.news
(
US Patent 11,232,363 B2
) · created by
d-e-v.com
buzzwords.technology
main_menu
Home
Channels
Personalize
Headlines
Alexa Skill
Search
Search
Home
Headlines
Novartis : Phase III Trial Results Show Sustained Efficacy & Long-term Safety Of Fabhalta In PNH
posted:
Sun, 12/10/2023 - 22:35 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
OPEC members push against including fossil fuels phase-out in COP28 deal
posted:
Sat, 12/09/2023 - 02:21 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Anixa Biosciences Announces Positive Data From Phase 1 Study Of Breast Cancer Vaccine; Stock Up
posted:
Wed, 12/06/2023 - 20:12 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Fossil fuel 'phase out' put on table for COP28 climate talks
posted:
Tue, 12/05/2023 - 01:20 EST
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Draft text at COP28 shows negotiators considering fossil fuel 'phase out'
posted:
Mon, 12/04/2023 - 23:53 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Draft text at COP28 shows negotiators considering fossil fuel 'phase out'
posted:
Mon, 12/04/2023 - 23:36 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Standard Lithium Updates On Phase 1A Project At LANXESS; Engages Citi For Strategic Financing
posted:
Mon, 12/04/2023 - 02:16 EST
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Immunovant Announces Positive Initial Data From Phase 1 Study Of IMVT-1402
posted:
Tue, 11/28/2023 - 08:12 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Carisma Therapeutics Gets FDA Clearance To Start Phase 1 Study Of CT-0525 In Solid Tumors
posted:
Tue, 11/28/2023 - 07:22 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
MorphoSys : Phase 3 Study Of Pelabresib Combination In Myelofibrosis Meets Primary Endpoint
posted:
Mon, 11/20/2023 - 20:29 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Bayer Stops Phase III Study Of Asundexian In Atrial Fibrillation Due To Lack Of Efficacy
posted:
Sun, 11/19/2023 - 20:46 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Karuna Announces Positive Results From Phase 1b BP Monitoring Trial Of KarXT In Schizophrenia
posted:
Fri, 11/17/2023 - 02:33 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
AstraZeneca : Phase III Trial Of Imfinzi + Chemoradiotherapy In Lung Cancer Fails To Meet Main Goal
posted:
Tue, 11/14/2023 - 02:50 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Exelixis Announces Encouraging Results From Phase 1b Trial Of Zanzalintinib In Kidney Cancer
posted:
Fri, 11/10/2023 - 09:29 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Novartis : Phase III Studies Of Remibrutinib In Chronic Spontaneous Urticaria Meet Main Goal
posted:
Thu, 11/09/2023 - 20:50 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Pagination
Previous page
‹‹
Page 7
Next page
››